Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Eckert & Ziegler Strahlen- und Medizintechnik AG
EUZEckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany. Address: Robert-ROessle-Str. 10, Berlin, Germany, 13125
Analytics
Objectif de Cours de WallStreet
52.15 EURRatio C/B
21.9781Rendement du dividende
1.47 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés EUZ
Analyse des dividendes EUZ
Croissance des dividendes sur 5 ans
150 %Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
64 %Historique des dividendes EUZ
Valorisation des titres EUZ
financières EUZ
Résultats | 2019 | Dynamique |